Literature DB >> 7418268

Rosette-increasing factor released by PHA-stimulated mononuclear cells in vitro which augments active E and EA rosette formation.

M Kubota, T Yoshida, K Shinomiya, H Mikawa.   

Abstract

The supernatants of phytohaemagglutinin (PHA) stimulated mononuclear (MN) cells contained a factor that significantly increased active E and EA (IgG) RFC which belonged to T cells and such was termed 'rosette-increasing factor' (RIF). This factor was demonstrated after as early as 2 hr of cluture and remained stable thereafter. The production of the factor seemed to be independent of macrophages and was mainly by nylon wool-adherent T cells. Cycloheximide and cytochalasin B pretreatment of MN cells prior to the addition of PHA abolished the activity of the supernatants in a dose-dependent manner, whereas mitomycin C and colchicine had no effect. As active E-RFC and Fc (IgG) receptor-positive T cells are considered to be closely correlated with cell-mediated immunity, this factor may play an important role in cellular immune response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418268      PMCID: PMC1538950     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Rosette-forming cells, immunologic deficiency diseases and transfer factor.

Authors:  J Wybran; A S Levin; L E Spitler; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.

Authors:  E Pick
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

4.  Role of contractile microfilaments in the release of histamine from mast cells.

Authors:  T S Orr; D E Hall; A C Allison
Journal:  Nature       Date:  1972-04-14       Impact factor: 49.962

5.  Studies of a non-cytotoxic migration inhibitory factor from human leucocytes.

Authors:  R Christoforetti; P Fireman
Journal:  Nat New Biol       Date:  1973-02-14

6.  Cell migration inhibition factor released by antigen from human peripheral lymphocytes.

Authors:  D E Thor; R E Jureziz; S R Veach; E Miller; S Dray
Journal:  Nature       Date:  1968-08-17       Impact factor: 49.962

7.  Lymphocyte stimulation: transfer of cellular hypersensitivity to antigen in vitro.

Authors:  F T Valentine; H S Lawrence
Journal:  Science       Date:  1969-09-05       Impact factor: 47.728

8.  Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.

Authors:  R D Nelson; R W Leu
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

9.  Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

10.  Binding of aggregated gamma-globulin to activated T lymphocytes in the guinea pig.

Authors:  J A Van Boxel; D L Rosenstreich
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

View more
  2 in total

1.  Rosette-increasing factor (RIF) generated in vivo following PHA skin test.

Authors:  M Kubota; H Mikawa
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

2.  Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.

Authors:  S Hyodo; T Kishi; E Kittaka; T Suzawa; A Tanabe; Y Tanaka; T Sakano; T Usui
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.